$181M
Pharmaceutical Fraud
Case results are sourced directly from attorney websites by Injuria.ai's data infrastructure, which actively monitors 22,000+ personal injury law firms. They are not results obtained by ThatCarHitMe.com. Every case is unique and must be evaluated on its own facts. Prior results do not guarantee a similar outcome. The results shown are not necessarily representative of all results obtained by these firms.
Case Details
Settlement where Johnson & Johnson agreed to pay 36 U.S. states and the District of Columbia for improperly marketing its Risperdal antipsychotic drug for unapproved uses.
Additional Notes
J&J promoted Risperdal for uses not approved by FDA, including for children, Alzheimer's, dementia, depression, and anxiety. Florida received $11 million.